Global Exosome Diagnostics and Therapeutics Market 2019 by Company, Regions, Type and Application, Forecast to 2024

Table of Contents

1 Exosome Diagnostics and Therapeutics Market Overview

• 1.1 Product Overview and Scope of Exosome Diagnostics and Therapeutics
• 1.2 Classification of Exosome Diagnostics and Therapeutics by Types
  • 1.2.1 Global Exosome Diagnostics and Therapeutics Revenue Comparison by Types (2019-2024)
  • 1.2.2 Global Exosome Diagnostics and Therapeutics Revenue Market Share by Types in 2018
  • 1.2.3 Instrument
  • 1.2.4 Reagent
  • 1.2.5 Software
• 1.3 Global Exosome Diagnostics and Therapeutics Market by Application
  • 1.3.1 Global Exosome Diagnostics and Therapeutics Market Size and Market Share Comparison by Applications (2014-2024)
  • 1.3.2 Diagnostic
  • 1.3.3 Therapeutic
• 1.4 Global Exosome Diagnostics and Therapeutics Market by Regions
  • 1.4.1 Global Exosome Diagnostics and Therapeutics Market Size (Million USD) Comparison by Regions (2014-2024)
  • 1.4.1 North America (USA, Canada and Mexico) Exosome Diagnostics and Therapeutics Status and Prospect (2014-2024)
  • 1.4.2 Europe (Germany, France, UK, Russia and Italy) Exosome Diagnostics and Therapeutics Status and Prospect (2014-2024)
  • 1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Exosome Diagnostics and Therapeutics Status and Prospect (2014-2024)
  • 1.4.4 South America (Brazil, Argentina, Colombia) Exosome Diagnostics and Therapeutics Status and Prospect (2014-2024)
  • 1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Exosome Diagnostics and Therapeutics Status and Prospect (2014-2024)
• 1.5 Global Market Size of Exosome Diagnostics and Therapeutics (2014-2024)

2 Manufacturers Profiles

• 2.1 Aethlon Medical(US)
  • 2.1.1 Business Overview
  • 2.1.2 Exosome Diagnostics and Therapeutics Type and Applications
    • 2.1.2.1 Product A
    • 2.1.2.2 Product B
  • 2.1.3 Aethlon Medical(US) Exosome Diagnostics and Therapeutics Revenue, Gross Margin and Market Share (2017-2018)
• 2.2 Exosome Diagnostics(US)
  • 2.2.1 Business Overview
  • 2.2.2 Exosome Diagnostics and Therapeutics Type and Applications
    • 2.2.2.1 Product A
    • 2.2.2.2 Product B
  • 2.2.3 Exosome Diagnostics(US) Exosome Diagnostics and Therapeutics Revenue, Gross Margin and Market Share (2017-2018)
• 2.3 NanoSomix Inc.(US)
  • 2.3.1 Business Overview
  • 2.3.2 Exosome Diagnostics and Therapeutics Type and Applications
    • 2.3.2.1 Product A
    • 2.3.2.2 Product B
  • 2.3.3 NanoSomix Inc.(US) Exosome Diagnostics and Therapeutics Revenue, Gross Margin and Market Share (2017-2018)
• 2.4 Thermo Fisher Scientific (US)
  • 2.4.1 Business Overview
  • 2.4.2 Exosome Diagnostics and Therapeutics Type and Applications
    • 2.4.2.1 Product A
    • 2.4.2.2 Product B
  • 2.4.3 Thermo Fisher Scientific (US) Exosome Diagnostics and Therapeutics Revenue, Gross Margin and Market Share (2017-2018)
• 2.5 Malvern Instruments (UK)
  • 2.5.1 Business Overview
  • 2.5.2 Exosome Diagnostics and Therapeutics Type and Applications
    • 2.5.2.1 Product A
    • 2.5.2.2 Product B
  • 2.5.3 Malvern Instruments (UK) Exosome Diagnostics and Therapeutics Revenue, Gross Margin and Market Share (2017-2018)
• 2.6 System Biosciences(US)
  • 2.6.1 Business Overview
  • 2.6.2 Exosome Diagnostics and Therapeutics Type and Applications
    • 2.6.2.1 Product A
    • 2.6.2.2 Product B
  • 2.6.3 System Biosciences(US) Exosome Diagnostics and Therapeutics Revenue, Gross Margin and Market Share (2017-2018)
• 2.7 NX Pharmagen (US)
  • 2.7.1 Business Overview
  • 2.7.2 Exosome Diagnostics and Therapeutics Type and Applications
    • 2.7.2.1 Product A
    • 2.7.2.2 Product B
  • 2.7.3 NX Pharmagen (US) Exosome Diagnostics and Therapeutics Revenue, Gross Margin and Market Share (2017-2018)
• 2.8 Sistemic Inc(UK)
  • 2.8.1 Business Overview
  • 2.8.2 Exosome Diagnostics and Therapeutics Type and Applications
    • 2.8.2.1 Product A
    • 2.8.2.2 Product B
  • 2.8.3 Sistemic Inc(UK) Exosome Diagnostics and Therapeutics Revenue, Gross Margin and Market Share (2017-2018)
• 2.9 Capricor Therapeutics (US)
  • 2.9.1 Business Overview
  • 2.9.2 Exosome Diagnostics and Therapeutics Type and Applications
    • 2.9.2.1 Product A
    • 2.9.2.2 Product B
  • 2.9.3 Capricor Therapeutics (US) Exosome Diagnostics and Therapeutics Revenue, Gross Margin and Market Share (2017-2018)
• 2.10 Exiqon A/S (Denmark)
  • 2.10.1 Business Overview
  • 2.10.2 Exosome Diagnostics and Therapeutics Type and Applications
    • 2.10.2.1 Product A
    • 2.10.2.2 Product B
  • 2.10.3 Exiqon A/S (Denmark) Exosome Diagnostics and Therapeutics Revenue, Gross Margin and Market Share (2017-2018)

3 Global Exosome Diagnostics and Therapeutics Market Competition, by Players

• 3.1 Global Exosome Diagnostics and Therapeutics Revenue and Share by Players (2014-2019)
• 3.2 Market Concentration Rate
  • 3.2.1 Top 5 Exosome Diagnostics and Therapeutics Players Market Share
  • 3.2.2 Top 10 Exosome Diagnostics and Therapeutics Players Market Share
• 3.3 Market Competition Trend

4 Global Exosome Diagnostics and Therapeutics Market Size by Regions

• 4.1 Global Exosome Diagnostics and Therapeutics Revenue and Market Share by Regions
• 4.2 North America Exosome Diagnostics and Therapeutics Revenue and Growth Rate (2014-2019)
• 4.3 Europe Exosome Diagnostics and Therapeutics Revenue and Growth Rate (2014-2019)
• 4.4 Asia-Pacific Exosome Diagnostics and Therapeutics Revenue and Growth Rate (2014-2019)
• 4.5 South America Exosome Diagnostics and Therapeutics Revenue and Growth Rate (2014-2019)
• 4.6 Middle East and Africa Exosome Diagnostics and Therapeutics Revenue and Growth Rate (2014-2019)

5 North America Exosome Diagnostics and Therapeutics Revenue by Countries

• 5.1 North America Exosome Diagnostics and Therapeutics Revenue by Countries (2014-2019)
• 5.2 USA Exosome Diagnostics and Therapeutics Revenue and Growth Rate (2014-2019)
• 5.3 Canada Exosome Diagnostics and Therapeutics Revenue and Growth Rate (2014-2019)
• 5.4 Mexico Exosome Diagnostics and Therapeutics Revenue and Growth Rate (2014-2019)

6 Europe Exosome Diagnostics and Therapeutics Revenue by Countries

• 6.1 Europe Exosome Diagnostics and Therapeutics Revenue by Countries (2014-2019)
• 6.2 Germany Exosome Diagnostics and Therapeutics Revenue and Growth Rate (2014-2019)
• 6.3 UK Exosome Diagnostics and Therapeutics Revenue and Growth Rate (2014-2019)
• 6.4 France Exosome Diagnostics and Therapeutics Revenue and Growth Rate (2014-2019)
• 6.5 Russia Exosome Diagnostics and Therapeutics Revenue and Growth Rate (2014-2019)
• 6.6 Italy Exosome Diagnostics and Therapeutics Revenue and Growth Rate (2014-2019)

7 Asia-Pacific Exosome Diagnostics and Therapeutics Revenue by Countries

• 7.1 Asia-Pacific Exosome Diagnostics and Therapeutics Revenue by Countries (2014-2019)
• 7.2 China Exosome Diagnostics and Therapeutics Revenue and Growth Rate (2014-2019)
• 7.3 Japan Exosome Diagnostics and Therapeutics Revenue and Growth Rate (2014-2019)
• 7.4 Korea Exosome Diagnostics and Therapeutics Revenue and Growth Rate (2014-2019)
• 7.5 India Exosome Diagnostics and Therapeutics Revenue and Growth Rate (2014-2019)
• 7.6 Southeast Asia Exosome Diagnostics and Therapeutics Revenue and Growth Rate (2014-2019)

8 South America Exosome Diagnostics and Therapeutics Revenue by Countries

• 8.1 South America Exosome Diagnostics and Therapeutics Revenue by Countries (2014-2019)
• 8.2 Brazil Exosome Diagnostics and Therapeutics Revenue and Growth Rate (2014-2019)
• 8.3 Argentina Exosome Diagnostics and Therapeutics Revenue and Growth Rate (2014-2019)
• 8.4 Colombia Exosome Diagnostics and Therapeutics Revenue and Growth Rate (2014-2019)

9 Middle East and Africa Revenue Exosome Diagnostics and Therapeutics by Countries

• 9.1 Middle East and Africa Exosome Diagnostics and Therapeutics Revenue by Countries (2014-2019)
• 9.2 Saudi Arabia Exosome Diagnostics and Therapeutics Revenue and Growth Rate (2014-2019)
• 9.3 UAE Exosome Diagnostics and Therapeutics Revenue and Growth Rate (2014-2019)
• 9.4 Egypt Exosome Diagnostics and Therapeutics Revenue and Growth Rate (2014-2019)
• 9.5 Nigeria Exosome Diagnostics and Therapeutics Revenue and Growth Rate (2014-2019)
• 9.6 South Africa Exosome Diagnostics and Therapeutics Revenue and Growth Rate (2014-2019)

10 Global Exosome Diagnostics and Therapeutics Market Segment by Type

• 10.1 Global Exosome Diagnostics and Therapeutics Revenue and Market Share by Type (2014-2019)
• 10.2 Global Exosome Diagnostics and Therapeutics Market Forecast by Type (2019-2024)
• 10.3 Instrument Revenue Growth Rate (2014-2024)
• 10.4 Reagent Revenue Growth Rate (2014-2024)
• 10.5 Software Revenue Growth Rate (2014-2024)

11 Global Exosome Diagnostics and Therapeutics Market Segment by Application

• 11.1 Global Exosome Diagnostics and Therapeutics Revenue Market Share by Application (2014-2019)
• 11.2 Exosome Diagnostics and Therapeutics Market Forecast by Application (2019-2024)
• 11.3 Diagnostic Revenue Growth (2014-2019)
• 11.4 Therapeutic Revenue Growth (2014-2019)

12 Global Exosome Diagnostics and Therapeutics Market Size Forecast (2019-2024)

• 12.1 Global Exosome Diagnostics and Therapeutics Market Size Forecast (2019-2024)
• 12.2 Global Exosome Diagnostics and Therapeutics Market Forecast by Regions (2019-2024)
• 12.3 North America Exosome Diagnostics and Therapeutics Revenue Market Forecast (2019-2024)
• 12.4 Europe Exosome Diagnostics and Therapeutics Revenue Market Forecast (2019-2024)
• 12.5 Asia-Pacific Exosome Diagnostics and Therapeutics Revenue Market Forecast (2019-2024)
• 12.6 South America Exosome Diagnostics and Therapeutics Revenue Market Forecast (2019-2024)
• 12.7 Middle East and Africa Exosome Diagnostics and Therapeutics Revenue Market Forecast (2019-2024)

13 Research Findings and Conclusion

14 Appendix

• 14.1 Methodology